… Our findings provide up-to-date estimates of the prevalence of HIV drug resistance in people
initiating or re-initiating first-line ART and we found worrying increases in prevalence in all …

… -resistant tuberculosis and 19 012 patients with drug-sensitive disease. The pooled rates of
failure or relapse, or both, and acquired drug resistance with all drug … -resistant tuberculosis …

… drug resistance in regions hardest hit by the HIV pandemic. We aimed to do a global
assessment of drug resistance after virological failure with first-line tenofovir-containing ART. …

… drug resistance [1]. In 2017, 558,000 cases were estimated to … resistant to Rifampicin (R),
the most effective first-line anti-tuberculosis drug [1], with 82% suffering from multidrug-resistant …

… the prevalence of first-line anti-tubercular drug resistance of M. … , evaluation of first-line
anti-tubercular drug resistance in … It seems that the prevalence of drug resistance is higher than …

… a significant impact of NNRTI resistance on the effectiveness of first-line NNRTI-based ART
… drug resistance variants (>5%) in the effectiveness of first-line NNRTI-based ART regimens. …

… artemisinin and partner drug resistance through Asia requires changes in first-line therapy.
… one first-line anti-malarial regimen with another. The number of anti-malarial drug candidates …

… the standard first-line regimens since 2010. Few studies have evaluated the adherence,
virological outcome, and drug resistance in HIV patients receiving first-line antiretroviral therapy (…

… of drug resistance mutations among patients failing first-line antiretroviral therapy (ART). …
Individual difference was noted in drug resistance mutations among patients failing the first line …

… of resistance and susceptibility by Deeplex-MycTB and pDST data for the first-line drugs
obtained after … However, data included mainly mutations conferring resistance to first-line drugs. …